September 18, 2019
This is what ASF Funded Research can do!
A UNC Healthcare announced on September 17, 2019: The National Institutes of Health have awarded two separate grants totaling $6.1 million to Mark Zylka, PhD, director of the UNC Neuroscience Center.at the UNC School of Medicine.
One of these projects will test a CRISPR/Cas9-based gene therapy for Angelman syndrome in mice and human neurons. Zylka is the principal investigator for this project, which is funded by a $2.8-million grant from the National Institute of Neurological Disorders and Stroke.
See the full press release here.
The ASF has been funding Dr. Zylka’s research into Angelman Syndrome since 2011, including his initial study into CRISPR/Cas9 in 2016.
